Clinical trialPhase 3
REGEND001 in emphysematous COPD
NCT07828353
Planned 102 участника, multicenter randomized blinded placebo-controlled; из собственных airway basal stem cells пациента.
No news refers to this card yet.
Also in the catalogue
- AV-1959R vaccine in preclinical Alzheimer’s diseaseClinical trial
- First-in-human: autologous bone-marrow MSC infusion in severe osteoporosisClinical trial
- IB1001-303 (levacetylleucine in ataxia-telangiectasia)Clinical trial
- Finerenone vs placebo in premature ovarian insufficiencyClinical trial
- PIEZO-101 (Piezo Therapeutics)Clinical trial
- Urolithin A vs placebo (NIA)Clinical trial
Scales
Identifiers
- NCT
- NCT07828353
Original sources
Details
- Phase
- Phase 3
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.